Sign inJoin waitlistJoin the waitlist

Gabrielle Lapping-Carr

Assistant Professor of Pediatrics · Pritzker School of Medicine

Credentials: · ·

History

Pritzker School of Medicine
Present

Hematology and Medical Oncology
2015–2018
University of Chicago Hospital
2014–2015
Pediatrics
Case Western Reserve University/University Hospitals Cleveland Medical Center
2011–2014
Internal Medicine
Case Western Reserve University School of Medicine
2008–2011
University of Illinois College of Medicine
2004–2008

Research

Extracellular microvesicle microRNAs in children with sickle cell anaemia with divergent clinical phenotypes
British Journal of Haematology · 2016 · 41 citations
Neonatal Thrombocytopenia: Etiology and Diagnosis
Case report · Pediatric Annals · 2015 · Last of 3 authors · 24 citations
Circulating Extracellular Vesicles and Endothelial Damage in Sickle Cell Disease
Review · Frontiers in Physiology · 2020 · First of 4 authors · 20 citations

Eric Beyer
8 papers
RP
Radhika Peddinti
5 papers
Yifan Mao
5 papers
Wendy Darlington
3 papers
AW
Austin Wesevich
2 papers · 1 as a fellow
David Gozal
2 papers
Gianna Sparks
2 papers
Jill de Jong
2 papers
Sharjeel Syed
2 papers · 2 as a fellow
AK
Ahamed Khalyfa
1 paper
AO
Akosua Oppong
1 paper
Anthony Chang
1 paper

Clinical trials

Tocilizumab for Acute Chest Syndrome
Principal investigator · Recruiting · Phase 2
University of Chicago
2023–2027
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Site PI · Recruiting
Children's Oncology Group
2023–2029